Acute Kidney Injury: Gastrointestinal side effects of Zepbound (tirzepatide) like diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems if dehydration is severe
That pattern has already started with semaglutide and is expected for other GLP-1s.[7][17] 3
Choose room-temperature drinks
Youll usually stay on this dose for at least 4 weeks before moving to 7.5 mg, depending on how you feel and your clinicians advice
#Retatrutide #Obesity #WeightManagement #Diabetes #GLP1 #GIP #MetabolicHealth #Endocrinology #ClinicalResearch #HealthcareInnovation #Pharmacy To view or add a comment, sign in ' Eli Lilly and Company has announced positive topline results from two additional Phase III trials of retatrutide, its investigational first-in-class GIP/GLP-1/glucagon triple receptor agonist for obesity and related metabolic conditions
Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink)